Citatuzumab (Anti-EpCAM / TROP1 / CD326)
A2651
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameCitatuzumab (Anti-EpCAM / TROP1 / CD326)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionCitatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.
- Storage Instruction-20°C
- UNSPSC12352203